X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (170) 170
Patent (73) 73
Publication (5) 5
Book / eBook (4) 4
Book Chapter (1) 1
Book Review (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (52) 52
index medicus (43) 43
performing operations (42) 42
transporting (42) 42
male (39) 39
female (35) 35
animals (28) 28
middle aged (25) 25
adult (22) 22
chemistry (21) 21
land vehicles for travelling otherwise than on rails (20) 20
motor vehicles (20) 20
trailers (20) 20
aged (19) 19
metallurgy (19) 19
physics (19) 19
oncology (18) 18
cancer (16) 16
gastroenterology & hepatology (16) 16
analysis (15) 15
calculating (15) 15
computing (15) 15
counting (15) 15
physical or chemical processes or apparatus in general (15) 15
electric digital data processing (14) 14
treatment outcome (14) 14
electricity (13) 13
interferon (13) 13
microbiology (13) 13
purification (13) 13
separation (13) 13
biochemistry (12) 12
biochemistry & molecular biology (12) 12
chemical or physical processes, e.g. catalysis or colloidchemistry (12) 12
hepatitis c virus (12) 12
human necessities (12) 12
medicine & public health (12) 12
mice (12) 12
their relevant apparatus (12) 12
aged, 80 and over (11) 11
ageing (11) 11
beer (11) 11
clarification (11) 11
electric communication technique (11) 11
enzymology (11) 11
foods or foodstuffs (11) 11
foods, foodstuffs, or non-alcoholic beverages, not covered bysubclasses a23b - a23j (11) 11
hepatitis c (11) 11
liver (11) 11
mutation or genetic engineering (11) 11
other alcoholic beverages (11) 11
pasteurisation (11) 11
preparation thereof (11) 11
preservation (11) 11
preservation of foods or foodstuffs, in general (11) 11
rats (11) 11
retrospective studies (11) 11
spirits (11) 11
sterilisation (11) 11
their preparation or treatment, e.g. cooking, modification ofnutritive qualities, physical treatment (11) 11
their treatment, not covered by other classes (11) 11
vinegar (11) 11
wine (11) 11
care and treatment (10) 10
cell line, tumor (10) 10
expression (10) 10
japan (10) 10
molecular sequence data (10) 10
hcv (9) 9
hepacivirus - genetics (9) 9
infection (9) 9
ribavirin (9) 9
surgical oncology (9) 9
amino acid sequence (8) 8
antiviral agents - therapeutic use (8) 8
biotechnology & applied microbiology (8) 8
colorectal surgery (8) 8
data processing systems or methods, specially adapted foradministrative, commercial, financial, managerial, supervisoryor forecasting purposes (8) 8
gastroenterology (8) 8
hepatocellular carcinoma (8) 8
hepatology (8) 8
systems or methods specially adapted for administrative,commercial, financial, managerial, supervisory or forecastingpurposes, not otherwise provided for (8) 8
time factors (8) 8
virology (8) 8
abdominal surgery (7) 7
apoptosis (7) 7
asunaprevir (7) 7
chronic hepatitis c (7) 7
daclatasvir (7) 7
dna (7) 7
drug therapy, combination (7) 7
health aspects (7) 7
hepatitis (7) 7
hepatitis c, chronic - drug therapy (7) 7
medical research (7) 7
micrornas - genetics (7) 7
pictorial communication, e.g. television (7) 7
treatment of water, waste water, sewage, or sludge (7) 7
young adult (7) 7
antiviral agents - administration & dosage (6) 6
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (238) 238
Japanese (12) 12
French (11) 11
German (7) 7
Chinese (4) 4
Spanish (2) 2
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Gastroenterology, ISSN 0944-1174, 1/2018, Volume 53, Issue 1, pp. 119 - 128
Hepatitis C virus (HCV) infection is common in hemodialysis patients and worsens their prognosis, while antiviral therapy options are limited. Recently,... 
DAAs | Medicine & Public Health | Colorectal Surgery | Hemodialysis | Hepatology | Gastroenterology | Abdominal Surgery | HCV | Surgical Oncology | CKD | KIDNEY-DISEASE | METAANALYSIS | EFFICACY | SAFETY | COMBINATION | PLUS ASUNAPREVIR | THERAPY | DIALYSIS PATIENTS | GENOTYPE 1 INFECTION | GASTROENTEROLOGY & HEPATOLOGY | STAGE RENAL-DISEASE | Isoquinolines - adverse effects | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Imidazoles - administration & dosage | Male | Isoquinolines - pharmacology | Aged, 80 and over | Adult | Female | Retrospective Studies | Drug Therapy, Combination | Antiviral Agents - pharmacology | Imidazoles - adverse effects | Japan | Genotype | Treatment Outcome | Imidazoles - pharmacology | Hepatitis C, Chronic - drug therapy | Sulfonamides - pharmacology | Antiviral Agents - administration & dosage | Antiviral Agents - adverse effects | Sulfonamides - adverse effects | Aged | Sustained Virologic Response | Isoquinolines - administration & dosage | Sulfonamides - administration & dosage | Renal Dialysis | Virus diseases | Medical research | Analysis | Medicine, Experimental | Hepatitis C virus | Health aspects | Alanine | Liver | Exanthema | Transaminase | Clinical trials | Data processing | Hepatocellular carcinoma | Infections | Genotype & phenotype | Hepatitis | Fibrosis | Alanine transaminase | Hepatitis C | Kidney transplantation
Journal Article
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 4/2017, Volume 52, Issue 4, pp. 504 - 511
Daclatasvir and asunaprevir combination therapy has shown a high virological response for chronic genotype 1 hepatitis C virus (HCV)-infected patients.... 
Daclatasvir | Chronic hepatitis C | Medicine & Public Health | Resistance-associated variants | Colorectal Surgery | Hepatology | Gastroenterology | Abdominal Surgery | Older patients | Asunaprevir | Surgical Oncology | UNITED-STATES | RIBAVIRIN | VIROLOGICAL RESPONSE | PEGINTERFERON | VIRUS GENOTYPE 1B | PLUS ASUNAPREVIR | PEGYLATED INTERFERON | NULL RESPONDERS | INFECTION | HCV | GASTROENTEROLOGY & HEPATOLOGY | Predictive Value of Tests | Isoquinolines - adverse effects | Age Factors | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Imidazoles - administration & dosage | Male | RNA, Viral - blood | Viral Load | Young Adult | Aged, 80 and over | Adult | Female | Imidazoles - therapeutic use | Drug Therapy, Combination | Hepacivirus - drug effects | Hepacivirus - isolation & purification | Drug Administration Schedule | Antiviral Agents - therapeutic use | Imidazoles - adverse effects | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Drug Resistance, Viral - genetics | Sulfonamides - therapeutic use | Antiviral Agents - adverse effects | Adolescent | Isoquinolines - therapeutic use | Sulfonamides - adverse effects | Aged | Polymorphism, Single Nucleotide | Sustained Virologic Response | Isoquinolines - administration & dosage | Sulfonamides - administration & dosage | Care and treatment | Analysis | Aged patients | Drug resistance | Hepatitis C virus | Hepatitis C | Health aspects | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2015, Volume 10, Issue 9, p. e0137361
MicroRNA-214 regulates both angiogenic function in endothelial cells and apoptosis in various cancers. However, the regulation and function of miR-214 is... 
ANGIOGENESIS | MIR-214 | MULTIDISCIPLINARY SCIENCES | CERVICAL-CANCER CELLS | DOWN-REGULATION | GROWTH-FACTOR | EXPRESSION | BREAST | NEGATIVE REGULATOR | P53 | ANGIOSARCOMA | RNA, Small Interfering - genetics | Hemangiosarcoma - metabolism | Hemangiosarcoma - veterinary | Dog Diseases - metabolism | Neoplasm Proteins - physiology | Gene Expression Regulation, Neoplastic | 3' Untranslated Regions - genetics | Apoptosis - genetics | Male | Hemangiosarcoma - genetics | Molecular Targeted Therapy | Dog Diseases - pathology | Tumor Suppressor Protein p53 - physiology | RNA, Messenger - biosynthesis | RNA Interference | Cell Division | Female | Genes, Reporter | RNA, Neoplasm - physiology | RNA, Messenger - genetics | Dog Diseases - genetics | Animals | Cell Cycle | Dogs | Cell Line, Tumor | RNA, Neoplasm - genetics | MicroRNAs - genetics | MicroRNAs - physiology | Genetic aspects | MicroRNA | Research | Tumor proteins | Angiosarcoma | Apoptosis | Biotechnology | p53 Protein | Genes | Oncology | Activation | Metastasis | Drug development | Kinases | Cancer therapies | Liver cancer | Angiogenesis | Information science | Cell activation | Transfection | Restoration | Transcription activation | Tumorigenesis | MiRNA | Gene expression | Endothelial cells | Ribonucleic acids | MicroRNAs | Medical prognosis | Cell lines | Tumor suppressor genes | Mutation | Tumors
Journal Article
Journal Article
Bioconjugate Chemistry, ISSN 1043-1802, 06/2015, Volume 26, Issue 6, p. 1080
  Fluorogenic probes are useful as molecular tools in chemical biology because they can overcome noise associated with background emission. Previously, using a... 
Proteins | Peptides | Fluorescence | Kinases | Cells
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 10/2018, Volume 53, Issue 10, pp. 1142 - 1150
We aimed to describe the real-world efficacy and safety of combination therapy with ledipasvir and sofosbuvir (LDV/SOF) for chronic hepatitis C virus (HCV)... 
Chronic hepatitis C | Medicine & Public Health | Colorectal Surgery | Hepatology | Gastroenterology | Ledipasvir | Abdominal Surgery | Surgical Oncology | Sofosbuvir | Alpha-fetoprotein | ASUNAPREVIR | FIBROSIS | MARKERS | RISK | PHASE-3 | HEPATOCELLULAR-CARCINOMA | PREDICT | DACLATASVIR | GASTROENTEROLOGY & HEPATOLOGY | INTERFERON THERAPY | Japan - epidemiology | Prospective Studies | Red Cross | Humans | Middle Aged | Fluorenes - therapeutic use | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Risk | Hepatitis C, Chronic - complications | alpha-Fetoproteins - analysis | Liver Neoplasms - blood | Liver Neoplasms - etiology | Young Adult | Treatment Failure | Aged, 80 and over | Adult | Female | Carcinoma, Hepatocellular - etiology | Fluorenes - adverse effects | Retrospective Studies | Carcinoma, Hepatocellular - blood | Sofosbuvir - adverse effects | Benzimidazoles - adverse effects | Drug Therapy, Combination | Benzimidazoles - therapeutic use | Hepacivirus - drug effects | Sofosbuvir - therapeutic use | Liver Cirrhosis - drug therapy | Liver Cirrhosis - etiology | Antiviral Agents - therapeutic use | Hepatitis C, Chronic - drug therapy | Hepatitis C, Chronic - blood | Viral Nonstructural Proteins - analysis | Antiviral Agents - adverse effects | Liver Cirrhosis - pathology | Aged | Polymorphism, Single Nucleotide | Sustained Virologic Response | Medical research | Analysis | Liver | Medicine, Experimental | Genetic aspects | Hepatitis C virus | Health aspects | Cirrhosis | Hepatitis | Chronic infection | Hepatocellular carcinoma | Glycosylation | Hepatitis C | α-Fetoprotein | Patients | Genotypes | Glomerular filtration rate | Geriatrics
Journal Article